Role of A1 and A(2a) adenosine receptors in the opiate withdrawal syndrome

Research Communications in Alcohol and Substances of Abuse

Volumn 18, Issue 3-4, 1997, Pages 141-148

  Stella, Luigi ^a   De Novellis, Vito ^a   Maione, Sabatino ^a   Marabese, Ida ^a   Rossi, Francesco ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 (3 CHLOROSTYRYL)CAFFEINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; CYCLOHEXYLADENOSINE; DOPAMINE; MORPHINE SULFATE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; JUMPING; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SUSTAINED RELEASE PREPARATION; WET DOG SHAKES; WITHDRAWAL SYNDROME; WRITHING TEST;

EID: 0031402173     PISSN: 10808388     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Acquas, E., Carboni, E. and Di Chiara, G. (1991). Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur. J. Pharmacol. 193: 133-134.
2. Dragunow, M. and Faull, R.L.M. (1988). Neuroprotective effects of adenosine. Trends Pharmacol. Sci. 9: 193-194.
3. Ferré, S., Fuxe, K., von Euler, G., Johansson, B. and Fredhoml, B.B. (1992). Adenosine, dopamine interactions in the brain. Neuroscience 51:501-512.
4. Gomaa, A.A., Mohamed, L.H. and Ahmed, N.H (1989). Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine. Eur. J.Pharmacol. 170: 129-35.
5. 2-adenosine antagonist in vitro and in vivo. FEBS Lett. 323, 141-144.
6. Jaffe, J.H. (1990). Drug addiction and drug abuse. In: The Pharmacological Basis of Therapeutics. Ed. by Gilman A.G., Rall T.W., Nies A.S. and Taylor P., 552-573. Pergamon Press, New York.
7. Krystal, J.H., Rasmussen, K. and Aghajanian G.K. (1990). Excitatory amino acid antagonists for opiate withdrawal. Am. Psych. Assoc. Abstr. 143, 262.
8. Michalska, E. and Malec D. (1993). Agonist and antagonist of adenosine receptors and morphine withdrawal syndrome in rats. Pol. J. Pharmacol. 45: 1-9.
9. Photos, E, Rada, P., Mark, G.P. and Hoebel, B.G. (1991). Chronic morphine increases synaptic dopamine in the nucleus accumbens and naloxone decreases it unless withdrawal is blocked with clonidine. Soc. Neurosci. Abstr. 17: 822.
10. Rasmussen, K., Fuller R. W.; Stockton, M.E., Perry, K.W., Swinford, R.M. and Ornstein P. (1991). NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coenileus unit acetivity induced by opiate withdrawal. Eur. J. Pharmacol. 197: 9-16.
11. Rossetti, Z.L., Hmaidan, Y. and Gessa, G.L. (1992). Marked ihnibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 221: 227-234.
12. Rossetti, Z.L., Melis, L., Carboni, S. and Gessa, G.L. (1990). Dopamine release in tolerance and withdrawal from morphine or ethanol. Neurosci. Lett. 39: S184.
13. Stanishevskaia, A.V., Khristoliubova, N.A., Veksbina, N.L., Varfolomeev, S.O. and Anokhina, I.P. (1991). The action of low doses of bromocryptine in experimental morphine abstinence in rats. Farmakol. Toksikol. 54:15-17.
14. Stella, L., de Novellis, V., Maione, S., Leyva, J., D'Amico, M., Berrino, L., Filippelli, A. and Rossi, F. (1995). Relationship between purinergic and glutamatergic systems in the opiate withdrawal syndrome. Res. Commun. Molec. Pathol. Pharmacol 87: 55-56.
15. Tanganelli, S., Antonelli, T., Morari, M., Bianchi and C., Beani, L. (1991). Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci. Lett. 122: 270-272.
16. 2 receptor antagonists. Psychopharmacol. Berl.. 108:177-84.